Mark E. Schurdak

2.2k total citations
48 papers, 1.7k citations indexed

About

Mark E. Schurdak is a scholar working on Molecular Biology, Cancer Research and Biomedical Engineering. According to data from OpenAlex, Mark E. Schurdak has authored 48 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 11 papers in Cancer Research and 7 papers in Biomedical Engineering. Recurrent topics in Mark E. Schurdak's work include Carcinogens and Genotoxicity Assessment (9 papers), DNA Repair Mechanisms (6 papers) and 3D Printing in Biomedical Research (6 papers). Mark E. Schurdak is often cited by papers focused on Carcinogens and Genotoxicity Assessment (9 papers), DNA Repair Mechanisms (6 papers) and 3D Printing in Biomedical Research (6 papers). Mark E. Schurdak collaborates with scholars based in United States, United Kingdom and Japan. Mark E. Schurdak's co-authors include Kurt Randerath, D. Lansing Taylor, Lawrence A. Vernetti, Erika Randerath, Stephen W. Fesik, Susan E. Morgan-Lappe, Ramesh C. Gupta, Andrew M. Stern, Albert Gough and Kenneth M. Comess and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Hepatology.

In The Last Decade

Mark E. Schurdak

48 papers receiving 1.6k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Mark E. Schurdak 1.0k 443 182 171 151 48 1.7k
Natalia J. Martinez 1.7k 1.6× 574 1.3× 217 1.2× 66 0.4× 65 0.4× 46 2.2k
Thomas P. Mathews 1.5k 1.5× 703 1.6× 309 1.7× 53 0.3× 95 0.6× 41 2.2k
Sudhir Sahasrabudhe 2.1k 2.1× 743 1.7× 310 1.7× 160 0.9× 81 0.5× 35 3.3k
Philippe de Médina 1.3k 1.2× 719 1.6× 178 1.0× 77 0.5× 54 0.4× 58 2.1k
Robert A. Everley 1.3k 1.3× 134 0.3× 336 1.8× 48 0.3× 84 0.6× 40 2.3k
J. Vázquez 1.2k 1.2× 303 0.7× 615 3.4× 39 0.2× 85 0.6× 13 2.2k
Stefani N. Thomas 1.4k 1.3× 180 0.4× 192 1.1× 128 0.7× 78 0.5× 61 2.1k
Justin Kale 1.6k 1.5× 225 0.5× 329 1.8× 59 0.3× 61 0.4× 15 2.2k
Dale J. Christensen 1.5k 1.5× 205 0.5× 399 2.2× 92 0.5× 23 0.2× 48 2.4k
Xiangling Yang 2.0k 2.0× 1.5k 3.3× 433 2.4× 79 0.5× 46 0.3× 71 2.9k

Countries citing papers authored by Mark E. Schurdak

Since Specialization
Citations

This map shows the geographic impact of Mark E. Schurdak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Schurdak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Schurdak more than expected).

Fields of papers citing papers by Mark E. Schurdak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Schurdak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Schurdak. The network helps show where Mark E. Schurdak may publish in the future.

Co-authorship network of co-authors of Mark E. Schurdak

This figure shows the co-authorship network connecting the top 25 collaborators of Mark E. Schurdak. A scholar is included among the top collaborators of Mark E. Schurdak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark E. Schurdak. Mark E. Schurdak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miedel, Mark T., Mark E. Schurdak, Andrew M. Stern, et al.. (2025). Integrated Patient Digital and Biomimetic Twins for Precision Medicine: A Perspective. Seminars in Liver Disease. 45(4). 458–475. 2 indexed citations
2.
Miedel, Mark T., Jaideep Behari, Alejandro Soto–Gutiérrez, et al.. (2025). Validation of microphysiological systems for interpreting patient heterogeneity requires robust reproducibility analytics and experimental metadata. Cell Reports Methods. 5(4). 101028–101028. 2 indexed citations
3.
DeBiasio, Richard, Rodrigo M. Florentino, Jacquelyn A. Brown, et al.. (2024). Comparison of wild-type and high-risk PNPLA3 variants in a human biomimetic liver microphysiology system for metabolic dysfunction-associated steatotic liver disease precision therapy. Frontiers in Cell and Developmental Biology. 12. 1423936–1423936. 7 indexed citations
4.
Jane, Esther P., Daniel R. Premkumar, Brian Golbourn, et al.. (2020). Targeting NAD+ Biosynthesis Overcomes Panobinostat and Bortezomib-Induced Malignant Glioma Resistance. Molecular Cancer Research. 18(7). 1004–1017. 13 indexed citations
5.
Tsai, Emily J., Tong Ying Shun, Albert Gough, et al.. (2019). A High-Throughput Assay for DNA Replication Inhibitors Based upon Multivariate Analysis of Yeast Growth Kinetics. SLAS DISCOVERY. 24(6). 669–681. 5 indexed citations
6.
Gough, Albert, Andrew M. Stern, John Maier, et al.. (2017). Biologically Relevant Heterogeneity: Metrics and Practical Insights. SLAS DISCOVERY. 22(3). 213–237. 55 indexed citations
7.
D’Aiuto, Leonardo, Peter Dimitrion, James McNulty, et al.. (2017). Comparison of three cell-based drug screening platforms for HSV-1 infection. Antiviral Research. 142. 136–140. 21 indexed citations
8.
LaPorte, Matthew G., Raffaele Colombo, Atefeh Garzan, et al.. (2016). Optimization of pyrazole-containing 1,2,4-triazolo-[3,4-b]thiadiazines, a new class of STAT3 pathway inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(15). 3581–3585. 28 indexed citations
9.
Montelaro, Ronald C., Mark E. Schurdak, Charles R. Rinaldo, et al.. (2016). Selection of a potential diagnostic biomarker for HIV infection from a random library of non-biological synthetic peptoid oligomers. Journal of Immunological Methods. 435. 85–89. 11 indexed citations
10.
Warita, Katsuhiko, Colin H. Beckwitt, Mark E. Schurdak, et al.. (2014). Statin-induced mevalonate pathway inhibition attenuates the growth of mesenchymal-like cancer cells that lack functional E-cadherin mediated cell cohesion. Scientific Reports. 4(1). 7593–7593. 118 indexed citations
11.
Lu, Yiling, Mathias Müller, David M. Smith, et al.. (2011). Kinome siRNA-phosphoproteomic screen identifies networks regulating AKT signaling. Oncogene. 30(45). 4567–4577. 57 indexed citations
12.
13.
Schurdak, Mark E., et al.. (2007). Adaptation of an In Vitro Phospholipidosis Assay to an Automated Image Analysis System. Toxicology Mechanisms and Methods. 17(2). 77–86. 7 indexed citations
14.
Ng, Teresa I., Hongmei Mo, Edward Tam, et al.. (2007). Identification of host genes involved in hepatitis C virus replication by small interfering RNA technology. Hepatology. 45(6). 1413–1421. 105 indexed citations
15.
Comess, Kenneth M., Mark E. Schurdak, Martin J. Voorbach, et al.. (2006). An Ultraefficient Affinity-Based High-Throughout Screening Process: Application to Bacterial Cell Wall Biosynthesis Enzyme MurF. SLAS DISCOVERY. 11(7). 743–754. 54 indexed citations
16.
Morgan-Lappe, Susan E., Keith W. Woods, Mark E. Schurdak, et al.. (2005). RNAi-based screening of the human kinome identifies Akt-cooperating kinases: a new approach to designing efficacious multitargeted kinase inhibitors. Oncogene. 25(9). 1340–1348. 38 indexed citations
17.
Schurdak, Mark E., Martin J. Voorbach, Lan Gao, et al.. (2001). Complex Gel Permeation Assays for Screening Combinatorial Libraries. SLAS DISCOVERY. 6(5). 313–323. 14 indexed citations
18.
Chadha, Anju, et al.. (1991). Covalent Bonding of Bay-Region Diol Epoxides to Nucleic Acids. Advances in experimental medicine and biology. 283. 533–553. 83 indexed citations
19.
Schmeiser, Heinz H., Anthony Dipple, Mark E. Schurdak, Erika Randerath, & Kurt Randerath. (1988). Comparison of 32P-postlabeling and high pressure liquid chromatographic analyses for 7,12-dimethylbenz[a]anthracene–DNA adducts. Carcinogenesis. 9(4). 633–638. 37 indexed citations
20.
Randerath, Kurt, et al.. (1985). Postlabeling methods for carcinogen-DNA adduct analysis.. Environmental Health Perspectives. 62. 57–65. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Natalia J. Martinez Breakdown of academic impact, for papers by Thomas P. Mathews Breakdown of academic impact, for papers by Sudhir Sahasrabudhe Breakdown of academic impact, for papers by Philippe de Médina Breakdown of academic impact, for papers by Robert A. Everley Breakdown of academic impact, for papers by J. Vázquez Breakdown of academic impact, for papers by Stefani N. Thomas Breakdown of academic impact, for papers by Justin Kale Breakdown of academic impact, for papers by Dale J. Christensen Breakdown of academic impact, for papers by Xiangling Yang
Rankless by CCL
2026